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ABSTRACT
We previously identified a tight bidirectional phase coupling between the circadian clock and the
cell cycle. To understand the role of the CLOCK/BMAL1 complex, representing the main positive
regulator of the circadian oscillator, we knocked down Bmal1 or Clock in NIH3T33C mouse
fibroblasts (carrying fluorescent reporters for clock and cell cycle phase) and analyzed timing of
cell division in individual cells and cell populations. Inactivation of Bmal1 resulted in a loss of
circadian rhythmicity and a lengthening of the cell cycle, originating from delayed G2/M transi-
tion. Subsequent molecular analysis revealed reduced levels of Cyclin B1, an important G2/M
regulator, upon suppression of Bmal1 gene expression. In complete agreement with these
experimental observations, simulation of Bmal1 knockdown in a computational model for coupled
mammalian circadian clock and cell cycle oscillators (now incorporating Cyclin B1 induction by
BMAL1) revealed a lengthening of the cell cycle. Similar data were obtained upon knockdown of
Clock gene expression. In conclusion, the CLOCK/BMAL1 complex controls cell cycle progression at
the level of G2/M transition through regulation of Cyclin B1 expression.
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Introduction
The circadian clock and the cell cycle are two funda-
mental, highly dynamic, and evolutionary well con-
served biological oscillators that employ cyclic gene
expression and protein degradation to impose diur-
nal rhythmicity on behavior, physiology and meta-
bolism, and to drive cell division, respectively.
The mammalian circadian clock consists of a light-
entrainable central clock located in the hypothalamic
suprachiasmatic nucleus (SCN) of the brain, and per-
ipheral clocks situated in the individual cells of almost
all other tissues [1]. At the molecular level, the circa-
dian clock is based on intertwined positive and nega-
tive transcriptional-translational feedback loops [2].
In short, the positive elements of the circadian clock,
encoded by the Brain and Muscle Arnt-like protein-1
(Bmal1) and the Clock genes, form a heterodimer that
activates transcription of E-box promoter element
containing genes, including the core clock genes
Period (Per1 and Per2), Cryptochrome (Cry1 and
Cry2), and nuclear hormone receptor Rev-Erbα.
Once formed, PER and CRY proteins heterodimerize
and translocate to the nucleus where they inhibit
CLOCK/BMAL1-mediated transcription of E-box
genes, including their own [2]. Post-translational
modification events, including phosphorylation and
ubiquitination, target the PER and CRY proteins for
degradation by the 26S proteasome complex, which in
turn allows reactivation of CLOCK/BMAL1-mediated
transcription and initiation of a new circadian cycle
[3,4]. In addition, CLOCK/BMAL1-driven cyclic
expression of the Rev-Erbα gene (encoding an inhibi-
tor of ROR-driven Bmal1 expression) causes Bmal1
expression to oscillate, which confers robustness to the
circadian core oscillator. BMAL1 andCLOCKare also
responsible for the cyclic transcription of E-box-
containing clock-controlled genes (CCG) that couple
the circadian oscillator to a wide variety of physiolo-
gical pathways.
Similar to the circadian clock, the cell cycle
behaves as an oscillator in which cyclic expression
of key cell cycle molecules (i.e. cyclins) regulates cell
cycle progression in a sequential and unidirectional
manner [5,6]. Cyclins are produced at specific stages
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of the cell cycle and associate with their respective
constitutively expressed Cyclin-Dependent Kinase
(CDK) partner. The kinase activity of the cyclin-
CDK complexes triggers various events at specific
times during the cell cycle. In short, mitogenic sig-
nals prompt the expression of Cyclin D, which binds
to CDK4 and CDK6 and irreversibly drives the cell
through G1 phase and prepares it for replication.
The underlying signalling cascade includes activa-
tion of the Ccne1 and Ccna2 cyclin genes [7].
Cyclin E protein levels peak at late G1, resulting in
the formation of Cyclin E/CDK2 complexes that
initiate G1/S transition and subsequent DNA repli-
cation [8,9]. Cyclin A2 starts to appear during
S phase and, along with its catalytic subunit CDK2,
is essential for DNA replication and S phase progres-
sion [10–12]. Ablation of Cyclin A2 in cultured cells
blocks DNA synthesis and delays S phase progres-
sion [13,14]. Mitotic entry is triggered by Cyclin B1/
CDK1 [15]. Transcription of the Cyclin B1 gene
CcnB1 starts in S phase with Cyclin B1 protein levels
and Cyclin B1/CDK1 complex formation peaking at
late G2 [16,17]. However, Cyclin B1/CDK1 com-
plexes are initially kept in an inactive state by
WEE1 and MYT1 kinase-mediated phosphorylation
of specific CDK1 residues to avoid premature mito-
sis [17–19]. Once protein levels are sufficiently high,
Cyclin B1 triggers the de-phosphorylation of CDK1,
thereby activating its own (i.e. Cyclin B1/CDK1)
complex and promotes entry into mitosis [16]. In
conclusion, oscillations in the amount and activity of
the various Cyclin/CDK complexes are crucial for
cell cycle progression.
Multiple studies have provided evidence for
a strong connection between the circadian clock
and cell cycle in proliferating cells. Bjarnason and
coworkers have shown circadian variation in the
abundance of cell cycle proteins in human oral
mucosa [20]. Moreover, expression of clock genes
in human oral mucosa and skin was associated
with specific cell cycle phases. Notably, peak
expression of the Cyclin B1 gene Cnnb1 coincides
with that of the Bmal1 clock gene, while Per1
transcription coincides with the peak of p53
mRNA levels in late G1 [21]. Studies addressing
the molecular link between the circadian and cell
cycle oscillator have shown that the circadian clock
can affect the cell cycle at different levels. For
instance, expression of the G2/M inhibitor WEE1
is under circadian control via CLOCK/BMAL1
responsive E-box elements in the Wee1 gene pro-
moter [22]. Likewise, G1 to S transition has been
reported to be under circadian control through
CLOCK/BMAL1-mediated cyclic transcription of
the cell cycle inhibitor gene p21WAF1/CIP1 [23].
Furthermore, the multifunctional nuclear protein
NONO was found to bind to the promoter of the
p16-Ink4A cell cycle checkpoint gene and drive
circadian expression in a PER-dependent manner
[24]. Oppositely, the cell cycle regulator protein
CDK1 has been suggested to control the circadian
clock through phosphorylation of REV-ERBα,
which targets the latter protein for FBXW7α-
mediated degradation [25].
Besides those molecular links, initial studies
with NIH3T3 cells containing a fluorescent clock
reporter that allows time lapse imaging of the
circadian clock in individual proliferating cells
revealed that mitosis occurred at specific time
windows, suggesting that cell division is gated by
the circadian clock [26]. Recently, we and others
used aforementioned NIH3T3 cells to address the
dynamic coupling between the clock and cell cycle
in more detail by simultaneous single-cell time
lapse imaging of circadian clock performance and
cell cycle progression, the latter visualized through
mitotic events [27] or fluorescent cell cycle repor-
ters [28]. Interestingly, in the absence of external
resetting cues, the cell cycle and circadian clock
were shown to be phase locked in a 1:1 ratio, with
the clock reporter reproducibly peaking 5 h after
mitosis [27,28]. Notably, the length of the circa-
dian cycle in proliferating cells adjusted to that of
the cell cycle. On the other hand, synchronization
of the circadian clock by physiological cues (such
as dexamethasone) causes clustering of cell divi-
sions, indicating that the cell cycle is synchronized
via the circadian clock and that, accordingly, the
coupling between these two oscillators is bidirec-
tional [28]. The molecular nature of the coupling
of the circadian clock to the cell cycle nevertheless
remains to be determined. Mathematical models
for the circadian clock [29,30] and the cell cycle
[6,31] have been integrated into a comprehensive
computational model [32] that enables the in silico
analysis of the connection between the circadian
clock and the cell cycle based on the molecular
information provided in literature. This approach
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has provided new insight into the interaction of
these oscillating systems and the conditions under
which the cell cycle can be entrained by the circa-
dian clock as a function of both the strength of
coupling to the circadian clock and the duration of
the cell cycle prior to such coupling [32].
Although our knowledge on the coupling of the
circadian clock and cell cycle is steadily increasing,
relatively little is known on how genetic clock defects
affect the interaction between these two oscillatory
machineries. In the current study, we used our
NIH3T33C mouse fibroblast line with fluorescent
reporter genes for the circadian clock and cell cycle
phase [28] to investigate the role of the BMAL1 and
CLOCK proteins in cell cycle progression. We show
that cell cycle duration is prolonged after siRNA
mediated silencing of either Bmal1 or Clock expres-
sion, and provide insight into the mechanism under-
lying this effect. Moreover, we used the biological
data to probe and reinforce the computational model
for the coupled mammalian circadian clock and cell
cycle oscillators.
Results
Suppression of Bmal1 expression lengthens the
cell cycle
To study the role of BMAL1 in cell cycle progression,
we used NIH3T33C cells, expressing fluorescentmar-
kers for the circadian clock (Rev-Erbα-VNP fusion
protein; yellow), as well as G1 phase (hCdt1-
mKOrange fusion protein; red) and combined S,
G2, and M (hereafter referred to as S/G2/M) phase
(hGeminin-CFP fusion protein; blue) of the cell cycle
[28]. NIH3T33C cells were transiently transfected
with a siRNA targeting Bmal1mRNA or with a non-
targeting siRNA (used as a negative control) and are
hereafter referred to as siBmal1 and siCtrl cells,
respectively. Analysis of Bmal1 mRNA and BMAL1
protein levels in proliferating siBmal1 cells 72 hours
after transfection, revealed 74% down regulation of
Bmal1 gene expression in siBmal1 cell cultures (Fig
EV1A), resulting in a 71% reduction in BMAL1
protein (Fig EV1B) levels.
We first analysed clock performance and cell cycle
progression in siBmal1 and siCtrl cells (n = 50 indivi-
dual cells per condition) over a period of 72 hours
using live cell imaging confocal microscopy (see
Figure 1(a) for a representative example of time lapse
images of a siCtrl cell, spanning a complete G1/S/G2/
M cycle). In line with our previous data [28], prolifer-
ating siCtrl cells show robust rhythmic expression of
the clock marker and a tight phase coupling of the
circadian clock and cell cycle (Figure 1(b)). The period
of the cell cycle, as calculated from the interval
between two peaks of hCdt1-mKOrange expression,
is 17.1 ± 0.3 h (mean ± SE; Figure 1(c)). In marked
contrast, we observed a complete suppression of cir-
cadian oscillations and robust down regulation of Rev-
Erbα-VNPprotein levels in proliferating siBmal1 cells,
indicative for efficient knockdown of Bmal1 expres-
sion (Figure 1(b)). Moreover, knockdown of Bmal1
expression significantly (p < 0.001) increased cell cycle
length from 17.1 ± 0.3 h to 21.4 ± 0.5 h (mean ± SE;
Figure 1(c)).
Next, we quantified the length of G1 and S/G2/M
phase in siCtrl and siBmal1 cells. For simplicity, as
the FUCCI markers are indicators for either G1 or
S/G2/M phase rather than exact predictors of the
start and end of these cell cycle phases, we defined
the G1 phase as the interval between the peaks of
hGeminin-CFP and hCDT1-mKOrange expression,
and the S/G2/M phase as the interval between the
peaks of hCDT1-mKOrange and hGeminin-CFP
expression. As shown in Figure 1(c), the mean
length of the G1 phase in siCtrl cells (8.2 ± 0.2 h)
does not significantly differ (p = 0.2) from that in
siBmal1 cells (8.7 ± 0.3 h). Interestingly, the average
length of the S/G2/M phase significantly (p < 0.001)
increased from 9.0 ± 0.8 h in siCtrl cells to
13.0 ± 0.3 h in siBmal1 cells (Figure 1(c)).
Taken together, these results show that the
BMAL1 protein acts as a cell cycle period modulator.
Suppression of Bmal1 expression specifically
affects the G2 phase
The single-cell experiments show that silencing
Bmal1 expression lengthens the S/G2/M phase
of the cell cycle, but do not allow to discrimi-
nate between the three phases. To investigate
which specific cell cycle phase is prolonged, we
compared the cell cycle distribution of prolifer-
ating siCtrl and siBmal1 cells by flow cytometry
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of propidium iodide stained cells (Figure 2(a))
and quantified the cell cycle phase distribution
(Figure 2(b)). In line with the single-cell experi-
ments, we did not observe significant changes
in the percentage of G1 and S phase cells after
knockdown of Bmal1 expression (G1 phase:
53.5 ± 1.2% and 52.7 ± 0.5%; S phase:
31.4 ± 1.0% and 28.5 ± 0.3 for siCtrl and
siBmal1 cells respectively; mean ± SEM). On
the other hand, the percentage of G2/M cells
significantly (p = 0.01) increased from
13.4 ± 0.5% in siCtrl cells to 17.1 ± 0.3% in
siBmal1 cells (Figure 2(b)). In order to discri-
minate between G2 and M phase, we also
stained the cells with an antibody against the
mitosis-specific MPM-2 phosphoepitope on
DNA topoisomerase IIα. As shown in Figure 2
(c), the percentage of MPM2-positive cells is
comparable for proliferating siCtrl and siBmal1
cell cultures. From these data we conclude that
the observed lengthening of the S/G2/M phase
after knockdown of Bmal1 is solely due to an
increased duration of the G2 phase.
Suppression of Bmal1 expression specifically
affects Cyclin B1 expression
The observed lengthening of the combined S/G2/M
phase in siBmal1 cells (single-cell analysis) and
increased number of siBmal1 cells in the G2 phase
(flow-cytometry analysis) clearly point to
a regulatory role of BMAL1 in the kinetics of the
cell cycle. We therefore next examined the expres-
sion levels of the various cyclins in proliferating
siCtrl and siBmal1 cells by western blot analysis
(Figure 2(d)). Following quantification (Figure 2
(e)), the expression levels of Cyclin D1, Cyclin E,
and Cyclin A (important regulators of G1 phase, G1/
S transition and S phase, respectively) in siBmal1
cells did not significantly differ from those in siCtrl
cells. However, the Cyclin B1 (a driver of G2/M
transition) protein level is significantly (p = 0.03)
Figure 1. Cell cycle dynamics in siCtrl and siBmal1 cells. (a) Representative example of time series images of the nucleus of
a proliferating siCtrl (NIH3T33C) cell, stably expressing circadian clock (Rev-Erbα-VNP; yellow), as well as G1 (hCdt1-mKOrange; red)
and S/G2/M (hGeminin-CFP; blue) cell cycle markers. Shown are pictures at 1.5 hour time intervals over a 18 h period, spanning one
cell cycle. (b) Circadian clock performance and cell cycle progression in a siCtrl (left panel) and a siBmal1 cell (right panel). Plotted are
fluorescence intensities of each of the markers over a 48 hour period. The G1 phase is defined as the interval between the peaks of
hGeminin-CFP and hCDT1-mKOrange expression. Oppositely, the S/G2/M phase is defined as the interval between the peaks of
hCDT1-mKOrange and hGeminin-CFP expression. (c) Box plot showing the cell cycle period and G1 and S/G2/M cell cycle phase
length in siCtrl and siBmal1 cells (n = 50 cells per condition). Lowest and highest boundaries of the box indicate the 25th and 75th
percentiles, respectively. The whiskers above and below the box designate the 95th and 5th percentiles, respectively. The solid line
and cross within the box represent the median and mean value, respectively. *** p < 0.001 (Mann Whitney U test).
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Figure 2. Cell cycle phase distribution of siCtrl and siBmal1 cells. (a) Flow cytometric analysis of cell cycle phases in siCtrl and siBmal1
cells. Shown are representative examples of propidium iodide (PI) stained siCtrl and siBmal1 cells, analysed for DNA content (n = 3
experiments). The vertical axis indicates the relative number of cells and the horizontal axis indicates the relative PI fluorescence. The
2N and 4N peaks and intermediate region correspond to G1, G2/M and S phase, respectively. (b) Quantification of cell cycle phase
distribution of proliferating siCtrl and siBmal1 cells. Shown are the average cell numbers of the 3 independent experiments (each
performed in triplicate; 20,000 cell counts per triplicate). The data were compared using the two-tailed unpaired Student’s t-test.
Error bars indicate SE. ** p < 0.01. (c) Flow cytometry analysis of the number of mitotic cells. The bivariate dot plots show DNA
content (PI) and mitotic phosphoproteins content (MPM2 stain) on the X and Y axis, respectively. The box marks cells stained
positive for MPM2. (d) Western blot analysis of whole cell extracts from proliferating siCtrl and siBmal1 cells for Cyclin D1, Cyclin E,
Cyclin A, and Cyclin B1 proteins. Shown are representative examples of n = 3 independent experiments. Actin was used as a loading
control. (e) Average cyclin protein levels in proliferating siCtrl and siBmal1 cells (n = 3 independent experiments). Cyclin expression
levels were normalized against actin. Cyclin expression levels in control cells were set as 1. Error bars indicate SD (n = 3
experiments).
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reduced in siBmal1 cells. This suggests that the accu-
mulation of siBmal1 cells in G2 phase, and the delay
in G2/M transition, are caused by low levels of
Cyclin B1.
Suppression of Bmal1 expression causes an
overall reduction of Cyclin B1 expression
Obviously, aforementioned experiments with asyn-
chronously proliferating cells do not discriminate
between the various cell cycle phases. We therefore
set out to further investigate the expression and
kinetics of accumulation of the various cyclins in
cell cycle synchronized siCtrl and siBmal1 cells. To
this end, we used a single 24 hour thymidine block,
which causes cells to accumulate at G1/S boundary.
As shown by flow cytometry, after release from the
thymidine block siCtrl and siBmal1 cells proceed
through S phase and enterG2 phasewith comparable
kinetics (Fig EV2). Moreover, pulse-labeling of siCtrl
and siBmal1 cells with 5-ethynyl-2′-deoxyuridine
(EdU) for one hour at 1 h intervals after release
from the thymidine block (Figure 3(a)) revealed
that DNA synthesis (as detected by immunofluores-
cent labeling) in siCtrl and siBmal1 cells follows
similar kinetics, peaking 3 hours after thymidine
block release (Figure 3(b)). Assuming that the peak
in DNA synthesis represents mid-S phase, S phase in
siCtrl and siBmal1 cells is estimated to span 5 to
6 hours, which is in good agreement with the flow
cytometry data (30% S-phase cells at a cell cycle
length of 18 hours = 5.4 h). Next, we determined
Cyclin E (G1/S marker) and Cyclin A2 (S phase
marker) protein levels by western blot analysis in
siCtrl and siBmal1 cells harvested 0, 2, 4, 6, 8, and
10 hours after release from thymidine (Figure 3(c)).
Quantification of the cyclin levels (Figure 3(d,e))
revealed that kinetics of Cyclin E and Cyclin A2
were comparable to siCtrl cells, which is in complete
agreement with our observation that siBmal1 cells
show normal G1 and S phase progression.
Next, we determined Cyclin B1 protein levels in
siCtrl and siBmal1 cells after release from the thymi-
dine block. As shown in Figure 3(f,g), Cyclin B1 pro-
tein levels gradually increased in siCtrl cells, reaching
amaximum6h after thymidine release at themoment
when cells are in G2 phase. In line with our earlier
observation in asynchronously dividing cells (Figure 2
(d,f)), siBmal1 cells express the Cyclin B1 protein at
lower levels. Moreover, siBmal1 cells display impaired
induction of Cyclin B1 during G2 phase, which may
explain the delay in G2/M transition.
Last but not least, as WEE1 is an inhibitor of
Cyclin B/CDK1 activity and Wee1 expression is
under circadian control [22], we also analyzed afore-
mentioned protein samples for WEE1 expression
(Figure 3(h)). As expected, in the absence of the
CLOCK/BMAL1 transcription activator, siBmal1
cells express WEE1 protein at markedly reduced
level (Figure 3(i)). However, as reduced expression
of this negative regulator is expected to accelerate,
rather than delay G2 to M transition, the lower
WEE1 protein levels in siBmal1 cells do not explain
the delayed G2/M transition. Instead, our data
demonstrate that the circadian clock protein
BMAL1 is a modulator of cell cycle period that pro-
motes G2 to M transition through induction of
Cyclin B1 expression.
Suppression of Clock expression lengthens the
cell cycle and dampens Cyclin B1 expression
The question arises to what extent the observed mod-
ulation of G2/M transition is a specific function of the
individual BMAL1 protein, or whether this requires
CLOCK/BMAL1 heterodimerization. We therefore
transiently transfected NIH3T33c cells with a siRNA
targeting the Clock gene or with a non-targeting con-
trol siRNA to obtain siClock cells. Analysis of Clock
mRNA and CLOCK protein levels in proliferating
siClock and siCtrl cells 72 hours after transfection,
revealed 63% down regulation of Clock gene expres-
sion in siClock cell cultures (Fig EV1C), resulting in
a 88% reduction in CLOCK protein levels (Fig EV1D.
We next analysed clock performance and cell cycle
progression in siClock and siCtrl cells (n = 40 indivi-
dual cells per condition) over a period of 72 hours
using time-lapse confocal microscopy (for
a representative example, see Figure 4(a)). Like
siBmal1 cells, siClock cells are arrhythmic, as evident
from the loss of cyclic expression of the REV-ERBα
clock reporter, and proliferate significantly slower
(p = 0.03) than siCtrl cells (19.7 ± 0.3 h vs
18.7 ± 0.3 h per cycle; mean ± SEM). As shown in
Figure 4(b), theG1phasewas not significantly affected
in Clock knock down cells, as compared to siCtrl cells
(9.2 ± 0.2 h vs 8.5 ± 0.3 h; mean ± SEM p = 0.07).
Instead, the increased cell cycle period in siClock cells
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Figure 3. Cell cycle protein expression in siCtrl and siBmal1 cells. (a) Cytochemical analysis of DNA synthesis in cell cycle
synchronized siCtrl and siBmal1 cells after release from a 24 h thymidine block. Cells were harvested at 1 h intervals. Prior to
harvesting, cells were exposed to a 1 h pulse labelling with EdU. (b) S phase kinetics. Quantification of Edu incorporation by siCtrl
and Bmal1 cells during the 1 h pulse labelling interval, preceding cell harvesting. The Y axis indicates the mean fluorescence
intensity, corrected for the number of cells. The X axis indicates time of harvesting after thymidine release. Error bars indicate SD
(n = 3 experiments). The grey bar indicates the estimated time of S/G2 transition. (c, f and h) Western blot analysis of Cyclin E and
Cyclin A2 (c), Cyclin B1 (f) and WEE1 (h) protein levels in siCtrl and siBmal1 cells after release from a thymidine block. Shown are
representative examples of n = 3 independent experiments. Actin was used as a loading control. (d,e,g and i) Kinetics of Cyclin E (d),
Cyclin A2 (e), Cyclin B1 (g) and WEE1 (i) expression after release from a thymidine block. Expression levels were normalized against
actin. Expression levels in siCtrl cells at t = 0 were set as 1. Error bars indicate SD. The grey bar indicates the estimated time of S/G2
transition.
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Figure 4. Cell cycle dynamics and Cyclin B1 protein expression in siCtrl and siClock cells. (a) Circadian clock performance and cell
cycle progression in a siCtrl (left panel) and a siClock cell (right panel). Plotted are fluorescence intensities of each of the markers over
a 60 hour period. (b) Box plot showing the cell cycle period and G1 and S/G2/M cell cycle phase length in siCtrl and siClock cells
(n = 40 cells per condition). Lowest and highest boundaries of the box indicate the 25th and 75th percentiles, respectively. The
whiskers above and below the box designate the 95th and 5th percentiles, respectively. The solid line and cross within the box
represent the median and mean value, respectively. * p < 0.05; *** p < 0.001 (Mann Whitney U test). (c) Flow cytometric analysis of
cell cycle phases in siCtrl and siClock cells. Shown are representative examples of propidium iodide (PI) stained siCtrl and siBmal1
cells, analysed for DNA content (n = 3 experiments). The vertical axis indicates the relative number of cells and the horizontal axis
indicates the relative PI fluorescence. The 2N and 4N peaks and intermediate region correspond to G1, G2/M and S phase,
respectively. (d) Quantification of cell cycle phase distribution of proliferating siCtrl and siClock cells. Shown are the average cell
numbers of the 3 independent experiments (each performed in triplicate; 20,000 cell counts per triplicate). The data were compared
using the two-tailed unpaired Student’s t-test. Error bars indicate SE. * p < 0.05; ** p < 0.01. (e) Western blot analysis of Cyclin B1
protein levels in siCtrl and siClock cells after release from a thymidine block. Shown are representative examples of n = 3
independent experiments. Actin was used as a loading control. (f) Kinetics of Cyclin B1 expression after release from a thymidine
block. Cyclin B1 expression levels were normalized against actin. The Cyclin B expression level in siCtrl cells at t = 0 was set as 1. Error
bars indicate SD (n = 3 experiments).
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originates from a lengthened S/G2/M phase (9.4 ± 0.1
h in siCtrl and 11.0 ± 0.2 h in siClock cells; p < 0.001).
Subsequent analysis of the cell cycle distribution of
proliferating siCtrl and siClock cells by flow cytometry
revealed a significant increase in the percentage of G2/
M cells (14.3 ± 0.1 in siCtrl and 20.1 ± 1.2 in siClock
cells;mean±SEM; p= 0.03), and relatively less S phase
cells in proliferating siClock cell cultures (27.1 ± 0.6 in
siCtrl and 21.3 ± 1.0 in siClock cells; p = 0.01) (Figure4
(d)). These findings indicate that proliferating siClock
cells markedly resemble siBmal1 cells in that the cell
cycle period is increased due to slower G2/M cell cycle
progression.
We therefore next analyzed the kinetics of Cyclin
B1 accumulation in siClock and siCtrl cells after release
from a 24 hour thymidine block (Figure 4(d)). As
expected, Cyclin B1 protein levels gradually increased
in siCtrl cells peaking 6 hours after thymidine release
(Figure 4(e), see also Figure 3(g)). In contrast, siClock
cells show markedly reduced Cyclin B1 protein levels
peaking between 6 and 8 hours after thymidine release
(Figure 4(e)). Taken together, these data indicate that
modulation of G2/M transition through induction of
Cyclin B1 is a characteristic of the CLOCK/BMAL1
heterodimer, rather than the BMAL1 protein alone.
Mathematical modeling of CLOCK/
BMAL1-controlled cell cycle progression
The biological data on the modulating effect of
CLOCK/BMAL1 on cell cycle progression serve
as an ideal tool to probe and reinforce the compu-
tational model for coupled mammalian circadian
clock and cell cycle oscillators, as defined by
Goldbeter and coworkers [6,29,30,32]. We there-
fore set out to test whether the computational
model would also respond with a delay in G2/M
transition after simulating a reduction in Bmal1 or
Clock expression levels. The coupling between the
circadian clock and the cell cycle is mediated by
several cell cycle proteins such as WEE1 [22], p21
[23], NONO [24], and, as shown here, Cyclin B1.
Oppositely, there are indications that the cell cycle
may have an effect on the circadian clock, but the
mechanism of such a coupling remains unclear
[33,34], although a recent study points to the
enhancement of REV-ERBα degradation through
phosphorylation by CDK1 [25]. Therefore, despite
recent evidence for bidirectional coupling between
the cell cycle and the circadian clock [27,28], we
decided to focus on the situation where the cell
cycle is unidirectionally coupled to the circadian
clock via CLOCK/BMAL1-mediated induction of
Wee1 and Cnnb1 expression. Below, we first model
the impact of Bmal1 inactivation on cell cycle
progression, and subsequently address the effect
of in silico knockdown of Clock gene expression.
We consider that in proliferating cells the cir-
cadian clock has an overall length of 18 hours
(close to the value of 17.1 h observed experimen-
tally in proliferating siCtrl cells; Figures 1(b,c). We
select an autonomous period of the cell cycle of
21.1 h, which is close to the cell cycle length
observed in siBmal1 cells in the absence of the
circadian clock (Figure 1(b)). In line with the
experimental data (Figure 1(b)), the time evolution
of Bmal1 and Rev-Erbα mRNA levels in our com-
putational model shows that under control condi-
tions the circadian clock oscillates with a cycle
length of 18h (Figure 5(a)), while all four Cyclin/
CDK protein complexes (Figure 5(c)), as well as
the WEE1 protein (Figure 5(e)) display sustained
oscillations with the same period. These results
represent entrainment of the cell cycle by the
circadian clock via BMAL1-mediated induction
of Wee1 and CcnB1 (Cyclin B1) gene expression.
This circadian control comes on top of a basal
expression of the two genes, as suggested by the
observation of low levels of Cyclin B1 and WEE1
protein in siBmal1 cells (Figures 3(g,i)).
When Bmal1 gene expression is suppressed in
silico by reducing the Bmal1 mRNA synthesis rate
(vsB) by 70%, computational time series analysis
reveals that Bmal1 mRNA levels are no longer
oscillating and that BMAL1 protein levels are con-
stitutively low (Figure 5(b)). As a consequence,
Rev-Erbα mRNA levels are also constitutively low
(Figure 5(b)). These data are in full agreement
with the experimental data obtained with siBmal1
cells (Figure 1(b); Figs EV1A and EV1B) and show
that the circadian clock is arrested when Bmal1
expression is knocked down. Interestingly, and
also in full agreement with the experimental data,
the cell cycle length is prolonged from 18h to 21.1
h after in silico reduction of Bmal1 expression
levels (compare Figures 5(c,d)). Notably, the
width of the activity peak of Cyclin B/CDK1 is
significantly increased upon suppression of
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Figure 5. Computational modeling of the impact of Bmal1 knockdown on Cyclin/CDK levels. Analysis of the effect of silencing of
Bmal1 expression in the computational model for coupled mammalian circadian clock and cell cycle oscillators. The time series in the
upper panels show the evolutions of Bmal1 mRNA (dark cyan, solid line), total BMAL1 protein (dark cyan, dashed line) and Rev-Erbα
mRNA (orange) under normal conditions (a) or when the synthesis rate of Bmal1 mRNA is reduced by 70% (b). The period of the
circadian clock is 18h in control conditions. However, the oscillations in (b) disappear upon decreasing Bmal1 mRNA synthesis. The
time series in the middle panels show the time evolutions of Cyclin A/CDK2 (light green), Cyclin E/CDK2 (mustard green), Cyclin B/
CDK1 (blue) and CyclinD/CDK4-6 (red) in control conditions, when the cell cycle is synchronized to the circadian clock (c), or when
Bmal1 is knocked down (d). The period of the cell cycle increases from 18h in (c) to 21.1 h in (d). Also, the width of the activity peak
of Cyclin B/CDK1 (blue) is significantly increased. The time series in the bottom panels show the evolutions of Cyclin B/CDK1 (blue)
and WEE1 (black) when cells are in control conditions (c) or when Bmal1 gene expression is knocked down (d). The concentration of
WEE1 decreases in (d) due to the lack of induction Wee1 transcription by BMAL1. Parameter values used for numerical simulations
are listed in the SI appendix.
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Bmal1 expression, while that of other Cyclins
appears unaffected (Figures 5(c,d)). In addition,
the WEE1 protein concentration decreases in the
model after in silico Bmal1 knockdown due to the
lack of CLOCK/BMAL1-mediated induction of
Wee1 gene expression (Figures 5(e,f)).
Next, we examined in more detail how suppres-
sion of Bmal1 expression in our mathematical model
affects the duration of the G1 and S/G2/M cell cycle
phases. To this end, we defined the G1 phase as the
time from mid-decrease of Cyclin B/CDK1 to 30%-
decrease of Cyclin D/CDK4-6 levels and the S/G2/M
phase as the time from 30%-decrease of Cyclin D/
CDK4-6 to mid-decrease of Cyclin B/CDK1 levels
(see Figure 6(a,b)). Analysis of the computed time
series reveals that under normal conditions, the G1
and S/G2/M phases span 5.84 h and 12.19h, respec-
tively (Figure 6(a)), while in silico reduction of
Bmal1 mRNA synthesis by 70% results in G1 and
S/G2/M cell cycle phase lengths of 6.41 h and
14.74 h, respectively (Figure 6(b)). Thus, in line
with the experimental data (Figures 1(b,c)), elonga-
tion of the cell cycle period upon suppression of
Figure 6. Computational modeling of the impact of Bmal1 knockdown on cell cycle phase length. The time series in the upper
panels show the evolutions of Cylin D/CDK4-6 (red) and Cyclin B/CDK1 (blue) when the circadian clock is in control conditions (a) or
when Bmal1 expression is reduced by 70% (b). As in the corresponding Figure 4, the period of the cell cycle increases from 18 h in
(a) up to 21.1 h when Bmal1 expression is supressed (b). The black bars indicate the G1 phase (from mid-decrease of Cyclin B/CDK1
to 30%-decrease in Cyclin D/CDK4-6) and S/G2/M phase (from 30%-decrease in Cyclin D/CDK4-6 to mid-decrease of cyclin B/CDK1).
The durations of G1 and S/G2/M in (a) are 5.84 h and 12.19 h, respectively. The durations of G1 and S/G2/M in (b) are 6.41 h and
14.74 h, respectively. Thus, the S/G2/M phase contributes most to the prolongation of cell cycle duration upon knocking down
BMAL1. The time series in the lower panels show the evolutions of total Cyclin B (dashed blue line) in control conditions (c) or upon
suppression of Bmal1 RNA synthesis (d). The total amount of Cyclin B (free + complexed with the kinase CDK1 and its inhibitor p21)
decreases when Bmal1 expression is reduced.
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Bmal1 expression is predominantly caused by
lengthening of the S/G2/M phase.
The mathematical simulations, as shown above,
reveal a normal amplitude oscillation of Cyclin B/
CDK1 levels after 70% reduction of the Bmal1
mRNA synthesis, which appears to contrast some-
what with the experimental data, showing a 20–25%
reduction in Cyclin B1 protein levels. We therefore
also determined the time evolution of the total
Cyclin B1 protein level (free and complexed with
CDK1) under control conditions (Figure 6(c)) and
upon reduced Bmal1 gene expression (Figure 6(d)).
The results indicate that, as in the experimental
observations (see Figure 2(d)), total Cyclin B1 levels
decrease upon knocking down Bmal1, which holds
with the view that BMAL1 induces CcnB1 gene
expression, as reported above.
Similar results were obtained upon knocking
down Clock instead of Bmal1 in the computational
model for coupled mammalian circadian clock and
cell cycle oscillators (data not shown), which may
not come as a surprise as CLOCK and BMAL1 act
as a heterodimeric complex.
In conclusion, the performance of the computa-
tional model for coupled mammalian circadian
clock and cell cycle oscillators after simulation of
Bmal1 or Clock silencing is in full agreement with
the experimental observations in proliferating
siCtrl, siBmal1 and siClock cells.
Discussion
Previously, we have reported the existence of a bi-
directional link between the circadian clock and
the cell cycle [28]. Indeed, synchronization and
resetting of the circadian clock by external cues
(such as dexamethasone) can synchronize cell
cycle progression. Oppositely, a clear shortening
of the circadian cycle occurred in dividing cells as
compared to non-dividing cells, suggesting that
the cell cycle can reset the circadian clock. In the
present study, we have taken a combined cell and
molecular biological approach to investigate the
impact of the circadian clock on cell cycle progres-
sion by genetic disruption of the molecular circa-
dian oscillator. We show that disruption of the
positive limb of the circadian transcription-
translation feedback loop-based molecular oscilla-
tor through knock-down of the circadian clock
genes Bmal1 or Clock prolonged the cell cycle of
cultured fibroblasts. Our results show that this
slowdown in cell cycle progression results from
a delay in the G2/M transition. Since inactivation
of Bmal1 or Clock triggers a highly comparable cell
cycle phenotype, G2/M checkpoint control appears
a function of the CLOCK/BMAL1 heterodimer,
rather than the individual proteins.
To investigate the molecular mechanism under-
lying the observed delay in cell cycle progression
in the absence of BMAL1 or CLOCK, we zoomed
in on cell cycle protein expression during G2
phase and G2/M transition using cell cycle syn-
chronized siBmal1 and siClock cells. Interestingly,
whereas the kinetics of S phase progression
remained unaffected, knockdown of Bmal1 or
Clock expression resulted in overall lower Cyclin
B1 protein levels, as well as a reduction of the
Cyclin B1 peak at G2 phase. Since a high Cyclin
B1 protein level is essential for G2 progression and
mitotic entry, the impaired induction of Cyclin B1
protein levels well explains the delayed cell cycle
progression in G2 phase. This view is consistent
with the study by Matsuo and coworkers [22]
focussing on cell cycle re-entry of remaining
mouse hepatocytes after partial hepatectomy at
ZT0 or ZT8 (ZT, Zeitgeber time in a 12 hour
light–12 hour dark cycle; ZT0 represents lights
on and ZT12, lights off). Whereas S phase kinetics
was independent of the time of surgery, CcnB1
mRNA and Cyclin B1 protein levels, as well as
Cyclin B1/CDK1 peak activity, were delayed by
about 8 to 12 hours when partial hepatectomy
was performed at ZT0 as compared to ZT8 [22],
demonstrating that clock-controlled timing of
Cyclin B1 expression and activity is determining
G2/M transition.
It has been well established that expression of the
Wee1 gene, encoding an important kinase regulating
the G2/M checkpoint, is under direct control of the
CLOCK/BMAL1 complex [22]. As WEE1 acts as an
inhibitor of CDK1 to prevent premature mitotic
entry, one would expect inhibition of Bmal1 expres-
sion to accelerate cell cycle progression due to
a reduction of WEE1 protein level and kinase activ-
ity. On the contrary, however, we observed a delay in
G2/M transition of proliferating siBmal1 and siClock
cells, accompanied by a reduction in Cyclin B1 pro-
tein levels. It appears, therefore, that the CLOCK/
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BMAL1 complex regulates at the same time the
expression of an inhibitor (WEE1) and an activator
(Cyclin B1) of G2/M transition. Regardless of this
dual role of the CLOCK/BMAL1 complex in con-
trolling the G2/M checkpoint, the increased cell cycle
length of siBmal1 and siClock cells suggests that the
dominant effect of CLOCK/BMAL1 is to induce
expression of the Cyclin B1 encoding gene Cnnb1.
The induction of Wee1 by CLOCK/BMAL1 could
nevertheless contribute to further extending the
duration of the G2/M phase by enlarging the width
of the peak in CyclinB1/CDK1 in the absence of its
inhibitor WEE1 in siBmal1 cells. Such a counter-
intuitive effect is suggested by numerical simulations
of the mathemathical model for coupled clock – cell
cycle oscillators, which showed that induction of
Wee1 by CLOCK/BMAL1 can shorten the duration
of the cell cycle by reducing the half-width of the
peaks in Cyclin B1/CDK1 [32].
Understanding how transcription of the Cyclin
B1 gene CcnB1 is regulated during the cell cycle
would help us to understand how BMAL1 can
modulate cell cycle progression. Promoter analysis
of the human CcnB1 gene uncovered four E-box
elements (CANNTG), one of which showing con-
sensus for the Upstream Stimulatory Factor (USF)
and acting as a G2-specific regulator of Cyclin B1
expression [35]. Since the USF E-box sequence
CACGTG matches that of the E-box elements
recognized by CLOCK/BMAL1, this results sug-
gest a direct role for BMAL1 in the G2-specific
induction of CyclinB1. However, the USF element
in the mouse promoter has a different sequence
and no longer matches the E-box sequence [36].
We therefore conclude that the effect of BMAL1
on Cyclin B1 levels must be indirect through (cyc-
lic) expression of other clock genes or clock-
controlled genes. A good candidate is P300,
which was shown to regulate transcription of
Cyclin B1 [36]. Furthermore, inhibition of P300
was shown to induce cell cycle arrest [37,38]. We
analysed expression of p300 in siCtrl and siBmal1,
and found that p300 is downregulated upon Bmal1
knockdown (Fig. EV3). This suggests that the
decreased Cyclin B1 levels in siBmal1 are a result
of lower levels of p300 induced transcription of
Cyclin B1.
BMAL1 has been shown to control expression
of the tumor suppressor gene p53 [39,40]. The p53
protein, in turn, has been suggested to prevent G2/
M transition by attenuating CcnB1 promoter activ-
ity and reducing Cyclin B1 protein levels [41].
Adding to the level of complexity of circadian
control of G2/M transition, the circadian clock
protein PER2 (expression of which is under con-
trol of CLOCK/BMAL1) can stabilize the p53 pro-
tein and influence its subcellular localization, i.e.
cytoplasmic vs nuclear [42].
The availability of a model for the coupling of the
cell cycle to the circadian clock in mammalian cells
allows us to probe, by means of computer simula-
tions, the effect of knocking down Bmal1 or Clock on
the dynamics of the cell cycle. Previous theoretical
investigations of this coupling [32] were based on the
circadian control of several components of the cell
cycle machinery, such as the kinase WEE1, the CDK
inhibitor p21, and Cyclin E. Here, the experimental
study confirmed that WEE1, a kinase that inhibits
CDK1, is under control of the circadian clock via the
induction of Wee1 expression by CLOCK/BMAL1.
The experiments uncovered an additional mode of
coupling due to the induction of CcnB1 expression
by CLOCK/BMAL1. We therefore incorporated
these two modes of coupling into the combined
model for the cell cycle and circadian clock in mam-
malian cells.
The model indicates that the induction of Ccnb1
andWee1 expression by CLOCK/BMAL1 allows the
cell cycle to synchronize with to the circadian clock
at a period in the order of 18h. Upon suppression of
BMAL1 expression by reducing the Bmal1 mRNA
synthesis rate by 70%, the circadian clock stops
ticking and the cell cycle recovers its autonomous
period of oscillation, close to 21h. The lengthening
of the period in our mathematical model is largely
due to an increase of a few hours in the duration of
the S/G2/M phase, which is in good agreement with
the experimental data. The simulations suggest that
this increase can be related to an increase in the half-
width of the peak in CDK1. The larger duration of
the peak in CDK1 is due to the decreased inhibition
of the enzymatic activity by WEE1, given that the
level of this inhibitory kinase drops when knocking
down its inducer BMAL1. In this respect it is inter-
esting to note that inactivation of BMAL1 in hippo-
campal neurons both experimentally and in silico
causes a cell cycle effect, i.e. delayed cell cycle
exit [43].
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Disruption of the circadian clock (genetically or
environmentally) results in altered cell prolifera-
tion, and in some cases cancer predisposition.
However, only few studies have been performed
to detect the intracellular pathways or the key
molecules responsible for the altered proliferation
capacity. Our study addressed the role of BMAL1
and CLOCK in the expression of Cyclin B1, one of
the key molecules for G2 phase and G2/M transi-
tion. The question arises whether the reduced
Cyclin B1 protein levels in the absence of
CLOCK/BMAL1 are the result of (i) the inactiva-
tion of the positive limb of the circadian transcrip-
tion translation feedback loop, or (ii) a complete/
overall loss of the clock. Future experiments with
circadian clock deficient Cry1/Cry2 knockdown
NIH3T33C cells should provide an answer to this
question.
Finally, stable gene silencing of Cyclin B1 has
been reported to inhibit proliferation, and sensi-
tizes breast cancer cells to taxol treatment [44].
Downregulation of Cyclin B1 via knock-down of
Bmal1 could be an attractive strategy for anti-
proliferative therapy. This might ultimately delay
tumor progression. However, the state of circadian
clock and cell cycle coupling in cancer cells still
remains to be studied.
Materials & methods
Cell culture and gene knockdown
NIH3T3 and NIH3T33c cells, the latter containing
Rev-Erbα-VNP clock reporter and FUCCI hCdt1-
mKOrange and hGeminin-CFP FUCCI cell cycle
reporter genes [28] were cultured in Dulbecco’s
Modified Eagle’s Medium (DMEM)/F10 (Lonza)
containing 10% Fetal Bovine Serum (FBS)
(Gibco), 100 U/ml Penicillin and 100 µg/ml
Streptomycin in a standard humidified incubator
at 37°C and 5% CO2 (pH7.7).
To knockdown Bmal1 or Clock expression, we
used Silencer® Select Pre-designed siRNA for Arntl
(ThermoFisher Scientific; catalog number
4390771) and Clock (ThermoFisher Scientific; cat-
alog number 4390771). As a negative control, we
used Silencer® Select Negative Control No. 1
siRNA (ThermoFisher Scientific; catalog number
4390843). Reverse transfection was performed in 6
well plates (population studies) or in 4 well poly-
L-lysine coated glass bottom dishes (D141410,
Matsunami Glass Ind.), using the Lipofectamine®
RNAiMAX method (Invitrogen) as described by
the manufacturer, except that Opti-MEM was
replaced by (serum-free) DMEM/F10. After
24 hours, transfection medium was replaced by
regular culture medium. Cells were harvested at
the indicated time points and processed for further
analysis.
In a subset of experiments, the cell cycle of
proliferating cells was synchronized by treatment
of cell cultures with 2.5 mM thymidine (Sigma),
starting 48 hours after RNAi transfection. After
24 hours, cells were released from thymidine
block by washing 3 times with PBS and harvested
at the indicated time points.
Time-lapse fluorescence microscopy
For time-lapse recording of circadian clock and cell
cycle progression, cells (transfected and grown on
glass bottom dishes) were placed in the temperature
(37°C), CO2 (5%) and humidity controlled chamber
of a live cell imaging Zeiss LSM510/Axiovert 200M
confocal microscope, equipped with a 10x Ph objec-
tive. Images were recorded every 30 min for
72 hours or more using a Coolsnap HQ/Andor
Neo sCMOS camera. Live cell imaging was con-
ducted using the following parameters (as set up in
Zeiss 200 software): Venus (green): 1000 ms (filter
cube: Ex = 475/40 nm, DM = 500 nm, Em = 530/50
nm); mKO2 (red): 300 ms (filter cube: Ex = 534/
20 nm, DM = 552 nm, Em: 572/38 nm); CFP (blue):
300 ms (filter cube: Ex = 458/17 nm, DM = 450 nm,
Em: 479/40 nm). Acquired images were concate-
nated and merged into a single file to generate
a movie which was used for further analysis as
described in detail by Feillet and coworkers
(Feillet et al., 2014). In short, single-cell numerical
time series for each of the fluorescent markers were
generated using the LineageTracker plugin for
ImageJ (https://github.com/pkrusche/lineage
tracker.jsonexport). Time series were analyzed for
circadian cycle length, cell cycle length and G1 and
S/G2/M cell cycle phase length. The G1 phase is
defined as the interval between the peaks of
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hGeminin-CFP and hCDT1-mKOrange expression.
Oppositely, the S/G2/M phase is defined as the
interval between the peaks of hCDT1-mKOrange
and hGeminin-CFP expression.
mRNA and protein analysis
Gene expression levels were determined by quanti-
tative RT-PCR. Total RNA was isolated from cul-
tured cells in triplicate using TRIzol (Invitrogen)
following manufacturer’s instructions. First-strand
cDNA was synthesized from 1 μg of total RNA
using oligo (dT) primers and SuperScript reverse
transcriptase (Invitrogen) according to the manu-
facturer’s protocol. Quantitative PCR amplification
was performed using the iCycler iQ™ Real-Time
PCR Detection System (BioRad), with SYBR-green
and primer sets generating intron-spanning pro-
ducts of 150–300 bp. The following forward and
reverse primers were used: Bmal1: Fwd 5ʹ-AAG
CTT CTG CAC AAT CCA CAG CAC-3ʹ and Rev
5ʹ-TGT CTG GCT CAT TGT CTT CGT CCA-3ʹ;
Clock: Fwd 5ʹ-CTT CCT GGT AAC GCG AGA
AAG −3ʹ and Rev 5ʹ-GTC GAA TCT CAC TAG
CAT CTG AC −3ʹ; B2M: Fwd 5ʹ-CCG GCC TGT
ATC CAG AAA-3ʹ and Rev 5ʹ-AAT TCA ATG
TGA GGC GGG TGG AAC-3ʹ.
Protein expression levels were determined by
Western blot analysis. Cells were lysed in RIPA lysis
buffer, composed of 2 mM Tris-HCl PH8.0, 1% TX-
100, 0.5% NaDOC, 0.1% SDS, 5.15 mM NaCl, 5 mM
NaF, 1.25 mM NaVO3, 10 mM EDTA supplemented
with a PhosSTOP phosphatase inhibitor tablet
(Roche) and a Pierce Protease Inhibitor tablet
(ThermoFisher). Lysates were cleared by centrifuga-
tion at 13,000 g for 10 minutes at 4°C. Protein con-
centration was determined using the BCA Protein
Assay Reagent (Pierce®, Thermo Scientific).
Absorbancewasmeasured at 560 nmusing aGloMax-
Multi+ Microplate Multimode Reader (Promega).
Proteins were loaded on Bis-Tris Plus 4–12% polya-
crylamide gel (Novex®, Life technologies), size sepa-
rated and transferred to a Polyvinylidene fluoride
(PVDF) membrane. After blocking with 4% skim
milk, membranes were incubated with a primary anti-
bodies (listed below) overnight at 4°C. After washing,
membranes were incubated with the secondary anti-
bodies (1:2000 dilution) for 1 hour at 4°C. Protein
bands were visualized using Western Lightning™
Chemiluminescence Reagent Plus (PerkinElmer) and
autoradiography. Bands were quantified by Fiji® soft-
ware and normalized against to β-actin protein levels.
Antibodies used: Primary antibodies: Actin C-2
(sc8432), BMAL1 (sc48790), CLOCK (sc25361),
Cyclin B1 (sc245), Cyclin A (sc751), and WEE1
(sc325) (all Santa Cruz), and Cyclin E (ab7959)
and Cyclin D (ab134175), and (all Abcam).
Secondary antibodies: goat anti-rabbit IgG (H + L)-
HRP conjugate or goat anti-mouse IgG (H + L)-
HRP conjugate.
Flow cytometry
To analyze cell cycle status by quantification of DNA
content, cells were harvested 48 hours after siRNA
transfection, washed with PBS, and fixed overnight
at 4°C with cold 70% ethanol. Next, fixed cells were
washed with PBS, treated for 15 min at 37°C with
PBS containing 100 μg/ml bovine pancreas RNase
(Calbiochem), and left overnight at 4°C in PBS with
40 μg/ml propidium iodide (PI; Life Technologies).
Alternatively, to specifically detect mitotic cells, fixed
cells were stained for the presence of the MPM-2
phospho-epitope on DNA topoisomerase IIα, using
mouse anti-MPM2 primary antibodies (Merck-
Millipore; dilution 1:200; 1 h on ice) and goat-anti
mouse FITC secondary antibodies (Jackson
ImmunoResearch; dilution 1:50; 30 min on ice).
Cells were analyzed by a Becton Dickinson
LSRFortessaTM Cell Analyzer (BD Biosiences). PI
and FITC fluorescence intensities were measured at
610 nm and 530 nm, respectively. For each condi-
tion, at least 20,000 cells were counted. Frequency
histograms were made using BD FACSDivaTM soft-
ware (BD Biosciences).
DNA synthesis assay
DNA synthesis was determined using the Click-iT®
EdU Alexa Fluor® 594 Imaging Kit (Invitrogen).
Cells were pulse labelled with 5-ethynyl-2ʹ-
deoxyuridine (EdU) for 1 hour, fixed with 3.7%
formaldehyde, and incubated with Alexa Fluor®
594 according to the manufacturer’s instructions.
Images were generated using a Zeiss Axiovert
200M microscope and processed using ImageJ
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software. For each image, total intensity was nor-
malized to the number of cells.
Mathematical modeling
To study the interaction between the circadian clock
and the cell cycle we used two computational models
previously proposed for the mammalian circadian
clock and for the mammalian cell cycle, respectively.
Themodel for themammalian circadian clock incor-
porates the positive and negative regulations invol-
ving the PER, CRY, CLOCK, BMAL1 and REV-ERB
α proteins [29,30]. This model (in which, for simpli-
city, PER1 and PER2, as well as CRY1 and CRY2 are
treated as single entities) accounts for the occurrence
of spontaneous circadian oscillations of the above-
mentioned proteins and their mRNAs in a variety of
experimental conditions.
The model for the mammalian cell cycle is
based on the regulatory properties of the CDK
network that drives the transitions between the
successive phases of the cell cycle [6,31]. The
model contains four CDK modules, each of
which controls the transition to a particular cell
cycle phase. Thus, Cyclin D/CDK4-6 and Cyclin
E/CDK2 promote progression in G1 and elicit the
G1/S transition; the activation of Cyclin A/CDK2
ensures progression in S and G2, while the peak of
Cyclin B/CDK1 activity brings about progression
into mitosis. Exit from the quiescent state is trig-
gered above a critical level of growth factor by the
synthesis of Cyclin D, which allows cells to enter
the G1 phase. Synthesis of the various cyclins is
regulated through the balance between the antag-
onistic effects exerted by the transcription factor
E2F and the tumor suppressor pRB, which respec-
tively promote and inhibit cell cycle progression.
Additional regulations in this model for the CDK
network bear on the control exerted by the pro-
teins SKP2, CDH1, or CDC20 on the degradation
of cyclins E, A, and B at the G1/S or G2/M transi-
tions, respectively. Moreover, the activity of each
cyclin/CDK complex can itself be regulated
through CDK phosphorylation-dephosphoryla-
tion. At suprathreshold levels of growth factor
sustained oscillations spontaneously occur in the
CDK network, which may be associated with cel-
lular proliferation since they correspond to the
repetitive, sequential activation of the various
cyclin-CDK complexes responsible for the ordered
progression along the successive phases of the cell
cycle [6,31].
The cell cycle is coupled to the circadian clock
through several molecular processes (see above),
such as the induction of Wee1 expression by
CLOCK/BMAL1. Such coupling may lead to
entrainment of the cell cycle by the circadian clock
[32]. The equations governing the models for the
coupled circadian clock and cell cycle models are
given in the Supporting Information section. Here
we focus on the case where the cell cycle is coupled
to the circadian control via the induction of Wee1
gene expression by CLOCK/BMAL1. We also intro-
duce coupling via the induction of Cnnb1 (Cyclin
B1) gene expression by CLOCK/BMAL1, as sug-
gested by the experiments reported in the present
study. To model the impact of knockdown of Bmal1
gene expression, we reduce the rate of Bmal1mRNA
synthesis (measured by parameter vsB) in the model
for the circadian clock.
Statistical analysis
All statistical analyses were carried out with
GraphPad software. For single-cell studies, after per-
forming the normality test, the two-tailed Mann-
Whitney U-test was used to analyze the period of
the circadian and cell cycle clocks (including G1, S/
G2/M phase length). For Western blot, flow cytome-
try, and immunofluorescence experiments, the two-
tailed Student’s t-test was applied.
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